CoverageForm 410-K10-Q8-K13D13G13F

Eiger Biopharmaceuticals, Inc.

EIGRCIK 0001305253 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 29, 2024. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback
Full filing:tone 0.0000

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Top insiders

Most active reporters at Eiger Biopharmaceuticals, Inc.

NameRolesFilings
Mayer Eldon C. III
Officer
6
Apelian David
OfficerDirector
3
Dietz Thomas John
Director
3
Murray Christine
Director
3
Atkisson Erik
Officer
2

Showing 1-5 of 16

Page 1 of 4Next

All filings

33 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue